Humanigen Inc (NASDAQ:HGEN) Stock Gains Momentum From Recent Lows
Clinical-stage biopharmaceutical firm Humanigen Inc (NASDAQ:HGEN) is involved in the development of lenzilumab, which is the first antigen in its class that not only binds but also helps in neutralizing…